News

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.
GE HealthCare Technologies Inc.’s GEHC share price has dipped by 15.96%, which has investors questioning if this is right ...
Ramside Spa is offering a Tranquil Escape Spa Break this April which includes spa treatments, dinner and an overnight stay ...
Endometriosis is a crisis – yet research, treatment and funding lag. Here, Scarlet Period and Rae founder, Jo Barry, shares ...
However, the role of nutrition in tuberculosis treatment is very underrated. The role of nutrition in tuberculosis treatment is very underrated.(AP) “A healthy diet is paramount for patients to ...
March 26 (UPI) --Japan accepted two Palestinians injured during the war in for medical treatment Wednesday ... announced Monday as it showcased images of its next-generation Chevrolet Corvette ...
Netlify/Decap CMS alternative. Fast, lightweight, Git-based headless CMS. Modern UX, first-class i18n support + 100s of improvements. Open source & free. Made with Svelte.
Jb Lacroix/FilmMagic via Getty Images, FILE The "Conclave" actor said that he now takes a synthetic thyroid hormone and undergoes regular blood tests to fine-tune his treatment. While he said the ...
42.80. Since then, the stock has retreated and is currently trading at Rs. 48.35 per equity share. Morepen Laboratories has launched Empamore, a new and affordable treatment for diabetes, heart ...
Sarepta Therapeutics said a patient taking its treatment for Duchenne muscular dystrophy has died from acute liver failure.
Sarepta Therapeutics Inc.’s stock tumbled 23% on Tuesday after the ... which is the only approved treatment for DMD, it had not yet been reported until now, Cambridge, Mass.- ...
Sarepta reported a patient death from acute liver failure after Elevidys treatment, though no new ... On Tuesday, Sarepta Therapeutics, Inc. SRPT stock is sliding. The company shared an update ...